Research, Charts & Company Announcements
Research Tree provides access to ongoing research coverage, media content and regulatory news on URALKALI PJSC. We currently have 0 research reports from 0 professional analysts.
Frequency of research reports
Research reports on
25 May 17
N+1 Singer - Small-cap quantitative research - Momentum screen refresh + 9 focus stocks
We have refreshed our momentum screen for a second time, the previous refresh having been in January. As before, the screen selects the 25 stocks exhibiting the strongest momentum, according to our measurement method. From these we selected 9 to focus on. Since the last refresh the screen has significantly outperformed both the main small-cap and micro-cap indices against a background of strong and stable momentum generally. We also present here a wider study of accelerating and decelerating momentum stocks, because of interesting behaviour noticed previously. The interim conclusion is that these two characteristics are a significant differentiator of performance. We show on pages 7 and 8 the current most accelerative and decelerative stocks.
Companies: SDM EYE SOG MAB1 GFIN FARN LRM W7L TET
25 May 17
N+1 Singer - Morning Song 25-05-2017
Clipper Logistics (CLG LN) Earnings enhancing acquisition | Conviviality (CVR LN) Raising a glass to a positive YE update | Halfords Group (HFD LN) Confidence in FX mitigations + staycation benefits | Sigma Capital Group (SGM LN) Successful launch of the UK’s maiden PRS REIT, raising £250m | Small-cap quantitative research Momentum screen refresh + 9 focus stocks
Companies: HFD SGM SDM EYE SOG CLG MAB1 CVR GFIN FARN LRM W7L TET
17 May 17
N+1 Singer - Morning Song 17-05-2017
ATTRAQT Group (ATQT LN) Integration progress; potential for significant cost savings | Bodycote (BOY LN) Good trading, in line with management expectations | Brewin Dolphin Holdings (BRW LN) Positive interims showing Q2 FuM growth and margin accretion | Grafenia (GRA LN) Net cash clarification | Listed Law Conference More listed legal services companies expected | Raven Russia Ltd (RUS LN) Raising funds for further opportunities | Synairgen (SNG LN)Full year results; LOXL2 inhibitor due to commence Phase I in H2 2017 | Zotefoams (ZTF LN) Positive start to the year
Companies: RUS BOY BRW MUR GRA SNG ATQT BUR DRV GTLY ZTF
23 May 17
N+1 Singer - Morning Song 23-05-2017
accesso Technology (ACSO LN) Strong start to FY 2017 | Avon Rubber (AVON LN) Contract award helps underpin forecasts for FY18 | eg solutions (EGS LN) Clear visibility of full year targets | Entertainment One Ltd (ETO LN) EPS and DPS in-line, Debt rises in line with last update | Scapa Group (SCPA LN) Forecast upgrades; momentum strong | UDG Healthcare (UDG LN) Strong interims, FY guidance raised 2% | 1Spatial (SPA LN) Onwards and upwards | Driver Group (DRV LN) Turnaround on track |
Companies: ETO AVON SCPA UDG SPA DRV EGS
23 May 17
Finals – Strong growth and a further upgrade
Finals reflect significant margin improvements within the Industrial division, the contribution from EuroMed, which was acquired in May 2016, and strong FX translation tailwinds due to weakness in sterling. Revenues increased 13.3% to £279.6m, (+1.7% constant FX) and with the trading margin improving from 8.6% to 10.4%, trading profits grew 37.1% to £29.2m (+18.2% constant FX). Adjusted PBT (excluding pension costs and exceptionals) was up 35.9% to £28.0m and, with a lower tax rate due to profits mix, adjusted EPS grew 39.6% to 14.8p. The dividend has been increased by 14.3% to 2.0p.
23 May 17
N+1 Singer - Scapa Group - Forecast upgrades; momentum strong
As indicated in April, the Group continued to trade strongly in H2 and FY17 trading profit was 5% ahead of our forecast. We have also increased our FY18 forecasts by c.8% as the momentum continues. The efficiency driven margin improvement in Industrials is ongoing as Rorschach closes, (mid teens margin target now set) whilst Healthcare has also driven margin improvement and has visibility of £200m from long term commercial agreements. We acknowledge the rising share price, but with momentum likely to continue, debt low (therefore M&A likely) and ongoing upside potential in the numbers, we have increased our target price to 467p (c.18x EBITDA) and remain at Buy.
16 May 17
Hardide* (HDD): Interim results, oil recovery and aerospace approvals bode well (CORP) | Premaitha Health* (NIPT): Trading update (CORP) | Akers Biosciences* (AKR): Q1 results (CORP) | Water Intelligence* (WATR): Growth strategy on track in a large, defensive market (CORP) | Frontier Developments* (FDEV): Elite Dangerous coming to PS4 (CORP) | K3 Business Technology* (KBT): Trading update (CORP)
Companies: HDD NIPT AKER WATR FDEV KBT
18 May 17
Small Cap Breakfast
I3 Energy –Schedule 1. Independent oil and gas company with assets and operations in the UK. Offer TBC, 26 May admission. | Opera Investments –Reverse Takeover of Kibo Mining’s subsidiary Kibo Gold. Raising £1.5m. Expected mkt Cap £6.5m. 23 May. | Verditek— Schedule 1 update. On Admission, the Company's subsidiaries will be involved in advanced solar photovoltaic, filtration and absorption technologies specialising in providing environmental services. Issue price 10p. Admission in late May. | AEW UK Long Lease REIT—Intention to Float. Up to £150m raise. Admission early June. UK specialist and alternative property | Alfa Financial Software –Intention to float. Mission-critical software platform purpose-built for asset finance enterprises. Vendor sale of 25% plus. FYDec16 rev £73.3m (CAGR of 24% from 2012). Adjusted EBIT £32.8m. | Kuwait Energy— $150m raise plus vendor offer. Admission due June. 2p reserves 810.0 mmboe | ADES International— Provider of offshore and onshore oil and gas drilling and production services in the Middle East and Africa, seeking raise up to $170m plus vendor sale under a Standard Listing of the Main Market. Admission due May 2017. | Tufton Oceanic Assets– Extended to 9 May on specialist funds segment of Main Market to enable further due diligence. |PRS REIT—Private rental sector REIT raising up to £250m. Admission due 31 May
Companies: STL HAL STAF CHH RENE DHG SFE FDBK EKT
24 May 17
Small Cap Breakfast
I3 Energy –Schedule 1. Independent oil and gas company with assets and operations in the UK. Offer TBC, 26 May admission. Verditek— Schedule 1 update. On Admission, the Company's subsidiaries will be involved in advanced solar photovoltaic, filtration and absorption technologies specialising in providing environmental services. Issue price 10p. Admission in late May. Tiso Blackstar Group—Schedule 1 update. Media, entertainment and marketing solutions group/ £160m mkt cap. Admission only. Expected late June. Curzon Energy—Report on Proactive Investors of intended LSE float this year with acquisition of coal bed methane assets in Oregon. Looking to raise £3m plus. NLB Group—financial and banking institution based in Slovenia, with a network of 356 branches. Seeking Ljubliana Stock Exchange listing with GDRs on the LSE. Expected mid June. Flying Brands (FBDU.L)—Prospectus approved by FCA. RTO of Stone Checker Software, supplier of technology solutions in the field of kidney stone analysis and prevention. Has raised £550k at 3p. Subject to GM on 15 Jun. AEW UK Long Lease REIT—Intention to Float. Up to £150m raise. Admission early June. UK specialist and alternative property Alfa Financial Software –Intention to float. Mission-critical software platform purpose-built for asset finance enterprises. Vendor sale of 25% plus. FYDec16 rev £73.3m (CAGR of 24% from 2012). Adjusted EBIT £32.8m. Kuwait Energy— $150m raise plus vendor offer. Admission due June. 2p reserves 810.0 mmboe ADES International— Provider of offshore and onshore oil and gas drilling and production services in the Middle East and Africa, seeking raise up to $170m plus vendor sale under a Standard Listing of the Main Market. Admission due May 2017. Tufton Oceanic Assets– Extended to 9 May on specialist funds segment of Main Market to enable further due diligence. PRS REIT—Private rental sector REIT raising up to £250m. Admission due 31 May
Companies: PYC CLTV HNL WAND TRAK OBT PSL ARL AGM
28 Apr 17
N+1 Singer - Morning Song 28-04-2017
Bagir Group (BAGR LN) NED appointment and acquisition update | T3 Trend spotting Strategy update
Companies: AUG GNS IQE NTG SDL SPH SDY TRI VEC XAR GHT BOY CRW EMIS VCT ECK GLE GHH DATA AVON CHH DPH HILS SDM ZYT MUR RPS LWB EKF SUN UDG SYNT CINE DOTD MPM BAGR FUM CLIN RENE ATQT MYSL SERV ERGO BCA BUR DRV SCS JUP FDP GBG GTLY HW/ EAH SFR PHD CXENSE KNOS NETD G4M GFIN FUTR ULS RHL RAT FEN LOOP
09 May 17
A brilliant half
Treatt has delivered yet another strong set of results. The business continues to perform very well and the constant stream of upgrades demonstrates the strength of momentum as the company moves further up the value chain. The pipeline is looking increasingly strong and recent growth means capacity expansion costing $11-14m is required at Treatt USA and is independent of the UK site relocation. We upgrade our FY18 and FY19 earnings estimates by c 2% and c 4%, respectively.
17 May 17
MagForce is moving forward with its strategy to drive uptake and acceptance (in the US and Europe) of its NanoTherm nanoparticle-based therapy for cancer. In Germany, Magforce has six centres commercially capable (three utilised, c50 patients to date) of treating glioblastoma (GBM) patients. To accelerate uptake of NanoTherm treatment in Europe, we expect Magforce to look to expand from Germany into other countries over six to 18 months. In the US, its subsidiary Magforce USA is in talks with the FDA to initiate a planned clinical trial in prostate cancer patients (potential launch in 2018). Data is expected in 2018 (potential launch soon after).
Companies: MAGFORCE AG
19 Jan 16
SP Angel Morning Report
Highfield Resources | Goldcrest Resources | Rio Tinto | Vedanta Resources | Shanta Gold
Companies: HFR RIO VED SHG
03 Feb 17
Small Cap Breakfast
Arix Bioscience — Intention to float on the main market from the global healthcare and life science company supporting medical innovation. Raised £52m in Feb 16 with investors including Woodford Investment Management Eco (Atlantic) Oil & Gas—Schedule One Update. Now expects admission ‘early February’. Ramsdens Holdings –Schedule One from the financial services provider and retailer, operating in the core business segments of foreign currency exchange, pawnbroking loans, precious metals buying and selling and retailing of second hand and new jewellery. Expected admission to AIM 15 Feb raising circa £15.6m. Expected mkt cap £26.5m.
Companies: HAYD MRL ZMNO SMS ADT EMH COR VOG ANP GRL
15 May 17
N+1 Singer - Victrex - Positive H1 underpins FY profit and special dividend expectations
Positive interims confirm a strong performance from the core business, which saw volume increase by 19%, more than offsetting the anticipated decline in consumer electronics demand. Volume and PBT increased by 5%, both representing 50% of our FY forecast. With further currency benefits to come and a normal H2 weighting, forecast upgrades might have been expected, but ongoing uncertainty over consumer electronics holds back this prospect for now. More positively, the special dividend (50p+ this year) now looks to be cemented and currency gains (£10m+ benefit o PBT) are also firming for FY18. The shares have passed our 2000p Target Price, and we are therefore at HOLD at this stage, but we remain strongly supportive of the medium term investment case.